TY  - GEN
AU  - Bocchia,Monica
AU  - Galimberti,Sara
AU  - Aprile,Lara
AU  - Sicuranza,Anna
AU  - Gozzini,Antonella
AU  - Santilli,Francesca
AU  - Abruzzese,Elisabetta
AU  - Baratè,Claudia
AU  - Scappini,Barbara
AU  - Fontanelli,Giulia
AU  - Trawinska,Monika Malgorzata
AU  - Defina,Marzia
AU  - Gozzetti,Alessandro
AU  - Bosi,Alberto
AU  - Petrini,Mario
AU  - Puccetti,Luca
TI  - Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients
SN  - 1949-2553
PY  - 2018///0223
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Atherosclerosis
KW  - blood
KW  - Cross-Sectional Studies
KW  - Cytokines
KW  - Dyslipidemias
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - Imatinib Mesylate
KW  - Incidence
KW  - Inflammation
KW  - chemically induced
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Oxidation-Reduction
KW  - drug effects
KW  - Polymorphism, Single Nucleotide
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Scavenger Receptors, Class E
KW  - genetics
KW  - Thrombosis
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.18632/oncotarget.11100
ER  -